Tonix Pharmaceuticals Initiates Enrollment in Second Potentially Pivotal Phase 3 Study, the RALLY Study, of TNX-102 SL for the Management of Fibromyalgia

Source :: Legal Monitor Worldwide. September 4, 2020
Publication Year :: 2020
Abstract: (GlobeNewswire) - Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the first participant was enrolled in the Phase 3 RALLY study [...]

Subjects :: Fibromyalgia
Cyclobenzaprine
Company business management
Business, international
Law

Tools